Based on the Escalon Medical Corp stock forecast from 0 analysts, the average analyst target price for Escalon Medical Corp is not available over the next 12 months. Escalon Medical Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Escalon Medical Corp is Slightly Bullish , which is based on 7 positive signals and 5 negative signals. At the last closing, Escalon Medical Corp’s stock price was USD 0.17. Escalon Medical Corp’s stock price has changed by +30.77% over the past week, -15.00% over the past month and -8.60% over the last year.
No recent analyst target price found for Escalon Medical Corp
No recent average analyst rating found for Escalon Medical Corp
Company Overview Escalon Medical Corp
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania. Read Less
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of t...Read More
Frequently Asked Questions About Escalon Medical Corp (ESMC) Stock
Stock Target Advisor's fundamental analysis for Escalon Medical Corp's stock is Slightly Bullish .
Unfortunately we do not have enough data on ESMC's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ESMC's stock to indicate what its average analyst target is.
ESMC stock's Price/Earning ratio is 16.00.
Our analysis grades ESMC stock's Price / Earning ratio at D-. This means that ESMC stock's Price/Earning ratio is above 38% of the stocks in the Medical Devices sector in the OTC exchange.
Based on this ESMC may be fairly valued for its sector
The last closing price of ESMC's stock was USD 0.17.
The most recent market capitalization for ESMC is USD 1.19M.
Unfortunately we do not have enough analyst data on ESMC's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Escalon Medical Corp's stock.
As per our most recent records Escalon Medical Corp has 40 Employees.
Escalon Medical Corp's registered address is 435 Devon Park Drive, Wayne, PA, United States, 19087.
You can get more information about it from Escalon Medical Corp's website at https://www.escalonmedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Escalon Medical Corp (ESMC) Stock
Stock Target Advisor's fundamental analysis for Escalon Medical Corp's stock is Slightly Bullish .
Unfortunately we do not have enough data on ESMC's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ESMC's stock to indicate what its average analyst target is.
ESMC stock's Price/Earning ratio is 16.00.
Our analysis grades ESMC stock's Price / Earning ratio at D-. This means that ESMC stock's Price/Earning ratio is above 38% of the stocks in the Medical Devices sector in the OTC exchange.
Based on this ESMC may be fairly valued for its sector
The last closing price of ESMC's stock was USD 0.17.
The most recent market capitalization for ESMC is USD 1.19M.
Unfortunately we do not have enough analyst data on ESMC's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Escalon Medical Corp's stock.
As per our most recent records Escalon Medical Corp has 40 Employees.
Escalon Medical Corp's registered address is 435 Devon Park Drive, Wayne, PA, United States, 19087.
You can get more information about it from Escalon Medical Corp's website at https://www.escalonmedical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ESMC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
